Multicenter study OPH 1001 - Research Coordinator



2010 - Research Coordinator of the 8 research centers in the multicenter study in Spain:
A phase 2, randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous injections of e10030 (anti-pdgf pegylated aptamer) given in combination with lucentis® in subjects with neovascular age-related macular degeneration - Protocol No. OPH 1001 – Trial ONGOING -Patients recruitment OPEN

  See article

Phase III Study OPKO
2008 – 2009: Principal Investigator. COBALT Study. A Phase 3, double-masked, parallel-assignment study of intravitreal...
+Read more

Phase 1 Study of ARC 1905 -Principal investigator and protocol...
2009 -Principal investigator and protocol co-designer - A phase 1 study to establish the safety and tolerability of ARC 1905...
+Read more

Phase III Study View 2
2009 – Ongoing: Co-Investigator. VIEW-2 Study. A Randomized, double masked, active controlled, phase 3 study of efficacy,...
+Read more

Phase II Study Raneovasc
2007 – 2009: Promotor and Principal Investigator. RANEOVASC Study. A Phase 2, prospective, controlled, open, randomized...
+Read more

Phase III multicenter Study TG-MV-007
2008 – 2009: Co-Investigator. TG-MV-007 Study. A Phase 3, double-masked, placebo-controlled, randomized trial of intravitreal...
+Read more